moksha8 is the Partner of Choice in the Emerging Growth Markets.
Our strategy is to build broad portfolios in our core markets, around
mature product deals with large pharmaceutical companies, and novel
product deals with mid-size pharmaceutical and biotech companies.
With exceptional commercialization expertise we maximize product
opportunities, and provide the highest quality healthcare for patients
and physicians.
Our therapeutic concentrations include CNS, Anti-infectives, Pain
and Cardiovascular. We are expanding into Oncology, Metabolic Disease
and other therapeutic areas.
For Business Development inquiries, please contact us at:
bd@moksha8.com
Our passion and focus on Emerging Markets provide a compelling value
proposition for our partners:
- Highest standards of business ethics and practices
- An exceptional, dedicated and entrepreneurial management team
with strong track record in international operations, commercialization
and business development
- Single, "one-stop-shop" partner across all Emerging
Markets provides multiple efficiencies for our partners
- Creativity and expertise to unlock value quickly
for products in the Emerging Markets benefiting our patients and partners
- Strong infrastructure and fully integrated commercialization
capabilities across all Emerging Markets to launch partner products
- World-class business development and alliance management
team that provides a seamless interface for our partners
- Valuable clinical and regulatory expertise to
support our partners' global registration studies
- Blue chip financial backing enabling all manner
of sizes and structures for our strategic alliances
For Business Development inquiries, please contact us at: bd@moksha8.com
